constitu
cimicifuga
plant
extens
investig
princip
metabolit
triterpenoid
glycosid
often
exhibit
extens
pharmacolog
activ
triterpenoid
glycosid
distribut
wide
genu
cimicifuga
rather
member
ranunculacea
famili
far
cycloartan
triterpen
glycosid
isol
cimicifuga
spp
aim
review
summar
triterpenoid
glycosid
base
avail
relev
scientif
literatur
biolog
studi
cycloartan
triterpen
glycosid
cimicifuga
spp
also
discuss
key
word
cimicifuga
spp
glycosid
chemic
structur
biolog
effect
clc
number
document
code
articl
id
receiv
genu
cimicifuga
one
smallest
genera
ranunculacea
famili
shown
possess
broad
rang
biolog
activ
antiinflammatori
antiheadach
antivir
cool
detoxif
antidiabet
antipyret
effect
sinc
first
medicin
descript
ancient
chines
medic
book
shengnong
bencao
jing
three
main
class
compound
isol
cimicifuga
spp
glycosid
chromon
cinnam
acid
deriv
triterpen
glycosid
consid
main
activ
compound
use
marker
compound
standard
cimicifuga
extract
thought
respons
pharmacolog
activ
plant
reliev
unpleas
symptom
associ
menopaus
especi
europ
unit
state
glycosid
isol
black
cohosh
cimicifuga
racemosa
wellknown
dietari
supplement
women
health
allevi
menstrual
pain
menopaus
disord
furthermor
anticanc
properti
genu
cimicifuga
receiv
lot
attent
recent
year
main
activ
constitu
still
thought
triterpenoid
show
inhibitori
effect
human
breast
cancer
liver
cancer
prostat
cancer
cell
line
due
antiosteoporosi
anticompl
activ
worth
note
triterpenoid
may
use
candid
develop
new
drug
cardiovascular
disord
due
antioxid
antiinflammatori
activ
public
number
glycosid
isol
cimicifuga
spp
pubm
recent
year
increas
rapidli
research
topic
gradual
becom
new
hotspot
therefor
review
structur
glycosid
biolog
activ
necessari
research
develop
compound
differ
triterpen
glycosid
cimicifuga
specis
describ
new
constitu
still
isol
aim
review
propos
classif
triterpen
deriv
isol
root
cimicifuga
spp
base
modif
carbon
skeleton
minor
rearrang
homolog
cleavag
degrad
summar
new
phytochem
report
natur
deriv
compound
type
period
well
biolog
activ
compound
report
compound
type
glycosid
characterist
system
proton
signal
high
field
region
around
ppm
gener
high
degre
oxid
usual
form
hemiacet
structur
furthermor
glycosid
substitu
usual
locat
signific
differ
structur
b
c
ring
differ
side
chain
divid
subtyp
shown
compound
identifi
list
tabl
structur
provid
fig
heracleifolinosid
heracleifolinosid
e
heracleifolinosid
f
cimiracemosid
g
cimignol
type
cimignol
type
unpreced
cycliz
unit
attach
side
chain
repres
signific
structur
variat
compound
class
c
nmr
reflect
c
h
nmr
cyclopropan
methylen
appear
h
c
nmr
signal
appear
c
c
c
respect
sinc
stereochemistri
known
compound
found
total
new
cimignol
analogu
obtain
identifi
cimicifuga
speci
structur
shown
fig
name
tabl
occasion
fuse
deriv
compound
triencimigenol
typic
spectral
data
show
two
proton
appear
h
togeth
c
cimicifoetisid
cimicifoetisid
b
exhibit
potent
cytotox
rat
ehrlichascit
carcinoma
human
breast
cancer
cell
ic
valu
cimicifoetisid
cimicifoetisid
b
respect
suggest
potenti
anticanc
agent
research
cimigenol
exhibit
moder
cytotox
cell
line
ic
valu
cimifoetisid
b
effect
inhibit
prolifer
murin
splenocyt
induc
concanavalin
ic
valu
main
structur
characterist
compound
configur
r
respect
carbonyl
acetoxi
group
instead
hydroxyl
group
report
cimigenoltyp
aglycon
potent
moder
activ
human
ht
cell
line
respect
base
analys
data
may
propos
cimigenoltyp
aglycon
hydrophob
group
carbonyl
acetoxi
instead
hydroxyl
group
essenti
cytotox
type
easi
recogn
characterist
structur
c
nmr
data
reflect
c
c
basic
around
c
around
c
furthermor
type
usual
divid
two
subclass
name
cimicidanol
cimicidol
accord
structur
cimicidanol
subtyp
possess
due
hydroxyl
dehydr
form
doubl
bond
around
c
cimicidol
own
usual
appear
c
addit
cimicidanol
around
c
compar
data
cimicidol
around
c
h
nmr
spectrum
cyclopropan
methylen
signal
exhibit
h
ppm
sinc
new
cimicidanol
subtyp
glycosid
isol
cimicifuga
genu
togeth
new
cimicidol
subtyp
glycosid
among
new
compound
possess
structur
furthermor
one
trinocimicidol
compound
one
cimifetidanosid
e
compound
isol
cimicifuga
speci
liu
et
al
report
heracleifolinosid
b
effect
resist
hypoxia
reoxygenationinduc
human
umbil
vein
endotheli
cell
injuri
cell
viabil
concentr
respect
indic
exhibit
good
antihypox
effect
dosedepend
manner
compar
arabinopyranosid
exhibit
appar
cytotox
cell
concentr
hgf
cell
show
weak
inhibit
activ
cell
line
ic
valu
major
characterist
type
often
contain
oxygen
substitut
includ
hydroxyl
carbonycl
acetyl
methoxyl
hemiacet
structur
signal
stabl
appear
around
c
c
respect
without
big
chang
meantim
glucosid
heracleifolinosid
f
move
lower
field
around
c
small
influenc
sinc
new
compound
found
belong
case
appear
c
around
c
immunosuppress
activ
studi
result
show
better
immunosuppress
activ
far
compound
name
isol
moreov
configur
r
might
r
hydroxyl
also
dehydr
form
doubl
bond
provid
highest
immunosuppress
activ
ic
valu
although
activ
far
lower
csa
data
mean
small
differ
structur
could
lead
remark
differ
immunosuppress
activ
futur
work
focu
correl
small
differ
structur
variat
immunosuppress
activ
type
compound
found
c
c
c
respect
distinguish
data
type
appear
around
h
peak
addit
chemic
shift
valu
may
help
use
judg
absolut
configur
brief
might
roh
around
c
togeth
c
might
soh
around
c
togeth
c
sinc
new
compound
isol
spectrum
data
suggest
kind
compound
highli
oxygen
triterpen
sevenr
structur
requir
fulfil
unsatur
requir
biggest
characterist
link
respect
oxobridg
besid
oxobridg
usual
exist
due
hydroxyl
group
form
oxygen
ring
configur
furthermor
two
hydroxyl
might
locat
respect
instead
oxobridg
sometim
secocycloartan
pharmacolog
studi
antiosteoporosi
activ
screen
vitro
indic
promot
prolifer
rat
osteoblastoma
cell
line
concentr
suggest
antiosteoporosi
activ
rel
low
concentr
hower
work
need
clarifi
mechan
protect
osteoporosi
effect
alkalin
phosphatas
akp
extern
signalregul
kinas
erk
activ
import
signal
pathway
osteoporosi
wt
mef
tumorigen
cell
line
use
test
activ
structur
target
mutat
result
show
yunnanterpen
e
nonselect
activ
cell
line
ic
valu
respect
howev
yunnanterpen
exhibit
greater
select
cell
wt
mef
cell
furthermor
yunnanterpen
exhibit
approxim
higher
select
wt
mef
cell
yunnanterpen
e
accord
result
mechan
action
yunnanterpen
worth
studi
advanc
way
futur
oxygen
bridg
import
featur
kind
compound
make
compound
six
ring
c
nmr
specif
chemic
shift
c
c
c
c
sinc
new
compound
isol
notabl
cimiracemosid
g
show
higher
cytotox
activ
tumor
cell
normal
hgf
suppress
prolifer
lymphocyt
ic
valu
furthermor
show
potent
immunosuppress
activ
mous
allogen
mix
lymphocyt
reaction
ic
respect
data
mean
compound
immunosuppress
activ
vitro
experi
vivo
done
demonstr
whole
profil
compound
immunosuppress
activ
inflammatori
cytokin
chemokin
express
immunosuppress
mice
includ
psoriasi
experiment
allerg
encephalomyel
eae
type
link
oxygen
bridg
alway
appear
c
side
chain
variabl
carbonyl
group
appear
c
form
oxygen
ring
r
r
side
appear
c
among
compound
littl
differ
convent
asiaticosid
type
due
side
chain
keton
group
instead
whole
side
chain
furthermor
occasion
carbonyl
group
cimidahusid
c
cimidahusid
alway
acetyl
group
sinc
kind
compound
shown
glucosid
xyl
new
compound
found
kind
cycloartan
glycosid
structur
peculiar
name
cc
bond
cleavag
import
structur
type
dring
open
becom
one
carbonyl
keton
group
togeth
one
keton
locat
furthermor
type
compound
still
possess
structur
often
occur
around
c
carboxyl
group
substitut
c
substitut
aldehyd
c
sinc
new
compound
isol
sever
speci
actual
compound
basic
structur
cycloartanetyp
due
simpl
skeleton
type
occasion
glycosid
glucos
xyl
best
knowledg
type
glycosidesaponin
cimicifuga
speci
addit
new
compound
isol
compar
control
amount
acth
secret
cell
significantli
increas
corticotrophin
releas
factor
crf
stimul
coincub
neocimicigenosid
neocimicigenosid
b
crf
significantli
enhanc
acth
secret
cell
thu
appear
promot
hypothalam
opituitaryadren
hpa
activ
may
lead
stress
resist
recov
foetidinosid
exert
moder
inhibit
cell
growth
ic
valu
respect
cimicifugadin
cycloartanetyp
compound
n
element
cimicifugadin
contain
one
nitrogen
atom
intrins
characterist
part
aglycon
structur
make
separ
group
review
mainli
discuss
phytochemistri
biolog
studi
triterpenoid
saponin
isol
genu
cimicifuga
sinc
thu
certain
degre
review
would
provid
use
data
research
interest
explor
develop
new
drug
cimicifuga
spp
especi
studi
menopaus
disord
relat
pure
compound
instead
focus
ethanol
extract
isopropanol
extract
root
cimicifuga
spp
research
investig
aspect
genu
cimicifuga
expand
medicin
applic
vitro
vivo
even
clinic
patient
best
knowledg
biolog
studi
triterpenoid
saponin
isol
genu
cimicifuga
enough
provid
suffici
evid
make
use
conclus
work
need
done
describ
whole
profil
triterpenoid
saponin
isol
genu
cimicifuga
chemic
biolog
perspect
studi
expand
immunosuppress
antiosteoporosi
review
attempt
emphas
new
research
direct
name
triterpenoid
glycosid
genu
cimicifuga
strongli
believ
biolog
studi
provid
valuabl
insight
regard
ethnomed
import
plant
